Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection

¹Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
²Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California;
³Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada;
⁴Department of Nuclear Medicine, Pomeranian Medical University, Szczecin, Poland;
⁵Department of Radiation Oncology, University of California San Francisco, San Francisco, California;
⁶Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California;
⁷Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada;
⁸Department of Molecular Imaging and Therapy, BC Cancer, Vancouver, British Columbia, Canada;
⁹Department of Radiology, San Francisco VA Medical Center, San Francisco, California; and
¹⁰Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California

For correspondence or reprints, contact Thomas A. Hope (thomas.hope{at}ucsf.edu).

Statistics from Altmetric.com